CELLeBRAIN presented at Korean Society for Clinical Pharmacology and Therapeutics – 2024 Annual Meeting
Author
admin
Date
2024-04-26 13:56
Views
170
KSCPT held its 17th spring meeting under the theme of ‘Clinical Pharmacology of Innovative Therapeutics’ in Jeju April 26, 2024. This spring meeting curated a diversity of presentations covering various aspects of cell-gene therapies including discovery, preclinical/clinical trials, and pharmacokinetic/pharmacodynamic evaluations.
Haeyoung Suh-Kim, CEO of CELLeBRAIN and a professor at Ajou University College of Medicine, conveyed important topics such as gene delivery capability to target site, a living anti-cancer drug with tumor targeting tropism, and first-in-human investigator-initiated trials. In addition, Suh-Kim emphasized effectiveness of add-on treatment in removing residual cancer cells after debulking surgery.
Haeyoung Suh-Kim, CEO of CELLeBRAIN and a professor at Ajou University College of Medicine, conveyed important topics such as gene delivery capability to target site, a living anti-cancer drug with tumor targeting tropism, and first-in-human investigator-initiated trials. In addition, Suh-Kim emphasized effectiveness of add-on treatment in removing residual cancer cells after debulking surgery.
Total 3
| Number | Title | Author | Date | Status | Votes | Views |
| 1 |
2024 INHA Univ. Hospital - Advanced Regenerative Medicine Symposium
admin
|
2024.06.17
|
Votes 0
|
Views 170
|
admin | 2024.06.17 | 0 | 170 | |
| 2 |
CELLeBRAIN presented its Novel Approach to Brain Cancer at BioUSA 2024
admin
|
2024.06.10
|
Votes 0
|
Views 165
|
admin | 2024.06.10 | 0 | 165 | |
| 3 |
CELLeBRAIN presented at Korean Society for Clinical Pharmacology and Therapeutics – 2024 Annual Meeting
admin
|
2024.04.26
|
Votes 0
|
Views 170
|
admin | 2024.04.26 | 0 | 170 |
